Emerald Advisers, LLC
- SEC CIK
- 0001015083
- Latest filing
- Aug 5, 2026
BBIO holding history
BridgeBio Pharma, Inc. in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −515,361−100.0% | Sold out | Holders |
| Q1 2026 | 515,361 | $38.3M | 1.2% | −20,403−3.8% | Reduced | Holders |
| Q4 2025 | 535,764 | $41.0M | 1.3% | −184,579−25.6% | Reduced | Holders |
| Q3 2025 | 720,343 | $37.4M | 1.2% | −300,914−29.5% | Reduced | Holders |
| Q2 2025 | 1,021,257 | $44.1M | 1.6% | −124,234−10.8% | Reduced | Holders |
| Q1 2025 | 1,145,491 | $39.6M | 1.8% | −5,377−0.5% | Reduced | Holders |
| Q4 2024 | 1,150,868 | $31.6M | 1.2% | +47,360+4.3% | Added | Holders |
| Q3 2024 | 1,103,508 | $28.1M | 1.1% | +437,164+65.6% | Added | Holders |
| Q2 2024 | 666,344 | $16.9M | 0.7% | −32,739−4.7% | Reduced | Holders |
| Q1 2024 | 699,083 | $21.6M | 0.9% | +13,544+2.0% | Added | Holders |
| Q4 2023 | 685,539 | $27.7M | 1.2% | −8,461−1.2% | Reduced | Holders |
| Q3 2023 | 694,000 | $18.3M | 0.9% | +214,875+44.8% | Added | Holders |
| Q2 2023 | 479,125 | $8.24M | 0.4% | +479,125 | New | Holders |